Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats

Neuroscience Letters

Volumn 619, Issue , 2016, Pages 106-113

  Motaghinejad, Majid ^a   Motevalian, Manijeh ^a   Shabab, Behnaz ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IranNajo Pharmaceutical Co   (Iran)

Author keywords

Hippocampus; Inflammation; Methylphenidate; Oxidative stress

Indexed keywords

GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROCORTISONE; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; METHYLPHENIDATE; TUMOR NECROSIS FACTOR ALPHA; CENTRAL STIMULANT AGENT; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HISTOLOGY; BRAIN MITOCHONDRION; CELL DENSITY; CELL NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DENTATE GYRUS; DENTATE GYRUS GRANULAR LAYER; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HYDROCORTISONE BLOOD LEVEL; LIPID PEROXIDATION; LOCOMOTION; LONG TERM CARE; MALE; MOBILIZATION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; REARING; ANIMAL; BLOOD; CELL COUNT; DOSE RESPONSE; DRUG EFFECTS; HIPPOCAMPUS; INFLAMMATION; METABOLISM; MITOCHONDRION; MOTOR ACTIVITY; PATHOLOGY; WISTAR RAT;

ANIMALS; CELL COUNT; CENTRAL NERVOUS SYSTEM STIMULANTS; DENTATE GYRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIPPOCAMPUS; HYDROCORTISONE; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MALONDIALDEHYDE; METHYLPHENIDATE; MITOCHONDRIA; MOTOR ACTIVITY; OXIDATIVE STRESS; PYRAMIDAL CELLS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84961133323     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.12.015     Document Type: Article

References (35)

1. Algahim M.F., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats. Pharmacol. Biochem. Behav. 2009, 92:93-99.
2. Andreazza A.C., Frey B.N., Valvassori S.S., Zanotto C., Gomes K.M., Comim C.M., Cassini C., Stertz L., Ribeiro L.C., Quevedo J. DNA damage in rats after treatment with methylphenidate. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1282-1288.
3. Babcock Q., Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J. Am. Coll .Health 2000, 49:143-145.
4. Banihabib N., Haghi M.E., Zare S., Farrokhi F. The effect of oral administration of methylphenidate on hippocampal tissue in adult male rats. Neurosurg. Q. 2015, 53:153-161.
5. Comim C.M., Gomes K.M., Réus G.Z., Petronilho F., Ferreira G.K., Streck E.L., Dal-Pizzol F., Quevedo J. Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder. Acta Neuropsychiatr. 2014, 26:96-103.
6. dela Peña I., Kim H.J., Sohn A., Kim B.-N., Han D.H., Ryu J.H., Shin C.Y., Noh M., Cheong J.H. Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD). Behav. Brain Funct. 2014, 10:10-17.
7. Dröge W., Breitkreutz R. Glutathione and immune function. Proc. Nutr. Soc. 2000, 59:595-600.
8. Fagundes A.O., Rezin G.T., Zanette F., Grandi E., Assis L.C., Dal-Pizzol F., Quevedo J., Streck E.L. Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats. Int. J. Dev. Neurosci. 2007, 25:47-51.
9. Gomes K.M., Petronilho F.C., Mantovani M., Garbelotto T., Boeck C.R., Dal-Pizzol F., Quevedo J. Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem. Res. 2008, 33:1024-1027.
10. Gonçalves J., Baptista S., Martins T., Milhazes N., Borges F., Ribeiro C.F., Malva J.O., Silva A.P. Methamphetamineçinduced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci. 2010, 31:315-326.
11. Gonçalves J., Martins T., Ferreira R., Milhazes N., Borges F., Ribeiro C.F., Malva J.O., Macedo T.R., Silva A.P. MethamphetamineçInduced Early Increase of IL-6 and TNF-α mRNA Expression in the Mouse Brain. Ann. N. Y. Acad. Sci. 2008, 1139:103-111.
12. Gopal K., Miller B., Gross G. Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro. J. Neural. Transm. 2007, 114:1365-1375.
13. Halliwell B. Free Radicals and Other Reactive Species in Disease 2005, 1-25. Wiley Online Library.
14. Huss M., Lehmkuhl U. Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. J. Atten. Disord. 2001, 6:S65-71.
15. Kayyal S., Trinh T., Dafny N. Adolescent and adult circadian rhythm activity modulated differently following chronic methylphenidate administration. J. Behav. Brain Sci. 2015, 5:56-68.
16. Krasnova I.N., Mccoy M.T., Ladenheim B., Cadet J.L. cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine. FASEB J. 2002, 16:1379-1388.
17. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 2001, 296:876-883.
18. Lagace D.C., Yee J.K., Bolaños C.A., Eisch A.J. Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis. Biol. Psychiatry 2006, 60:1121-1130.
19. Motaghinejad M., Karimian M., Motaghinejad O., Shabab B., Yazdani I., Fatima S. Protective effects of various dosage of Curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus. Pharmacol. Rep. 2015, 67:230-235.
20. Motaghinejad M., Karimian S.M., Motaghinejad O., Shabab B., Asadighaleni M., Fatima S. The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats. Fundam. Clin. Pharmacol. 2015, 29:299-309.
21. Motaghinejad M., Motevalian M., Ebrahimzadeh A. Reduction of methylphenidate induced anxiety, depression and cognition impairment by various doses of venlafaxine in rat. Int. J. Prev. Med. 2015, 6:20-28.
22. Motaghinejad M., Motevalian M., Larijani S.F., Khajehamedi Z. Protective effects of forced exercise against methylphenidate-induced anxiety, depression and cognition impairment in rat. Adv. Biomed. Res. 2015, 4:1-8.
23. Réus G.Z., Scaini G., Jeremias G.C., Furlanetto C.B., Morais M.O., Mello-Santos L.M., Quevedo J., Streck E.L. Brain apoptosis signaling pathways are regulated by methylphenidate treatment in young and adult rats. Brain Res. 2014, 1583:269-276.
24. Sadasivan S., Pond B.B., Pani A.K., Qu C., Jiao Y., Smeyne R.J. Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. PLoS One 2012, e33693.
25. Schmitz F., Pierozan P., Rodrigues A.F., Biasibetti H., Coelho D.M., Mussulini B.H., Pereira M.S., Parisi M.M., Barbé-Tuana F., de Oliveira D.L. Chronic treatment with a clinically relevant dose of methylphenidate increases glutamate levels in cerebrospinal fluid and impairs glutamatergic homeostasis in prefrontal cortex of juvenile rats. Mol. Neurobiol. 2015, 1-13.
26. Schmitz F., Scherer E.B., Machado F.R., da Cunha A.A., Tagliari B., Netto C.A., Wyse A.T. Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metab. Brain Dis. 2012, 27:605-612.
27. Seibert J., Hysek C.M., Penno C.A., Schmid Y., Kratschmar D.V., Liechti M.E., Odermatt A. Acute effects of 3, 4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects. Neuroendocrinology 2014, 17-25.
28. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., Iwata Y., Tsuchiya K.J., Suda S., Suzuki K. Methamphetamine causes microglial activation in the brains of human abusers. J. Neurosci. 2008, 28:5756-5761.
29. Simchon-Tenenbaum Y., Weizman A., Rehavi M. Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration. Behav. Brain. Res. 2015, 282:125-132.
30. Stopper H., Walitza S., Warnke A., Gerlach M. Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. J. Neural. Transm. 2008, 115:331-334.
31. Tagaya H. Methylphenidate: pharmacology, indication and potential of abuse. Nihon Rinsho 2010, 68:1550-1555.
32. Uys J.D., Mulholland P.J., Townsend D.M. Glutathione and redox signaling in substance abuse. Biomed. Pharmacother. 2014, 68:799-807.
33. Volkow N.D., Chang L., Wang G.-J., Fowler J.S., Leonido-Yee M., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.-S. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 2014, 377-382.
34. Volkow N.D., Fowler J., Wang G., Ding Y., Gatley S.J. Mechanism of action of methylphenidate: insights from PET imaging studies. J. Atten. Disord. 2001, 6:S31-43.
35. Yamamoto B.K., Bankson M.G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 2005, 17:87-118.